Stories from people navigating percutaneous coronary intervention — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories
Cardiology
A randomized-trial meta-analysis found less major bleeding with 3–6 months of DAPT after PCI than with 12 months, while major cardiovascular events were not significantly increased.
Rayan Salih · September 4, 2026 · 6 min
Cardiology
OPTIMA-AF supports stopping the P2Y12 inhibitor after 1 month in selected patients with atrial fibrillation undergoing PCI, reducing important bleeding without an apparent loss of thromboembolic protection.
Egbavwe Pela · 6 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.